Development of a time–temperature indicator (TTI) label by rotary printing technologies von Zabala, S., Castán, J., Martínez, C.

Volltext

A multilevel optimization approach to route design and flight allocation taking aircraft sequence and separation constraints into account von Ho-Huu, V., Hartjes, S., Pérez-Castán, J.A., Visser, H.G., Curran, R.

Volltext

Decision framework for the integration of RPAS in non-segregated airspace von Pérez-Castán, J.A., Gómez Comendador, F., Rodríguez-Sanz, A., Arnaldo Valdés, R.M., Águeda, G., Zambrano, S., Torrecilla, J.

Volltext

RPAS conflict-risk assessment in non-segregated airspace von Pérez-Castán, J.A., Gómez Comendador, F., Rodríguez-Sanz, A., Armas Cabrera, I., Torrecilla, J.

Volltext

Multichromophoric sensitizers based on calix[4]arene scaffold and 4H-pyranylidene moiety for DSSCs application von Colom, E., Andrés-Castán, J.-M., Franco, S., Garín, J., Montoya, J.-F., Orduna, J., Villacampa, B., Blesa, M.J.

Volltext

DSSCs based on aniline derivatives functionalized with a tert-butyldimethylsilyl group and the effect of the π-spacer von Duerto, I., Colom, E., Andrés-Castán, J.M., Franco, S., Garín, J., Orduna, J., Villacampa, B., Blesa, M.J.

Volltext

Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC Registry von Vilalta Castan, J

Volltext

Prevalence of abnormal urinary albumin excretion in elderly people: a Spanish survey von Robles, N. R., Felix, F. J., Fernandez-Berges, D., Perez-Castán, J., Zaro, M. J., Lozano, L., Alvarez-Palacios, P., Garcia-Trigo, A., Tejero, V., Morcillo, Y., Hidalgo, A. B.

Volltext

SEOM clinical guidelines for the management of metastatic breast cancer 2013 von Llombart Cussac, A., de la Haba Rodríguez, J., Ruiz Simón, A., Álvarez López, I., Cortés Castán, J.

Volltext

Impact of continuous climb operations on airport capacity von Pérez-Castán, J.A., Gómez Comendador, F., Rodríguez-Sanz, A., Barragán Montes, R., Arnaldo Valdés, R., Pérez Sanz, L.

Volltext

Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC Registry von Vilalta Castan, J.

Volltext

Individualization of treatment strategies von Fernández Ortega, Adela, Jolis López, Laura, Viñas Villaró, Gemma, Villanueva Vázquez, Rafael, García Arias, Alicia, González Farré, Xavier, González Jiménez, Sonia, Saura Manich, Cristina, Cortés Castán, Javier

Volltext

Modification of the electronic properties of the π-spacer of chromophores linked to calix[4]arene platform for DSSCs applications von Colom, E., Andrés-Castán, J.M., Barrios, D., Duerto, I., Franco, S., Garín, J., Orduna, J., Villacampa, B., Blesa, M.J.

Volltext

Dye-sensitized-solar-cells based on calix[4]arene scaffolds von Castillo-Vallés, M., Andrés-Castán, J. M., Garín, J., Orduna, J., Villacampa, B., Franco, S., Blesa, M. J.

Volltext

Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients von Cortes Castan, J., Pegram, M., Pivot, X., Curigliano, G., Lim, J.Y., Song, S., Yoon, Y.C.

Volltext

Settings-based efficacy comparison of trastuzumab biosimilars in breast cancer: A systematic literature review von Rugo, H.S., Curigliano, G., Cardoso, F., Gradishar, W.J., Pegram, M., Barrios, C.H.H., Cortes Castan, J., Pennella, E., Muniz, R.

Volltext

Multichromophoric sensitizers based on calix[4]arene scaffold and 4 H -pyranylidene moiety for DSSCs application von Colom, E., Andrés-Castán, J.-M., Franco, S., Garín, J., Montoya, J.-F., Orduna, J., Villacampa, B., Blesa, M.J.

Volltext

ATTAIN: Phase III study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (... von Tripathy, D., Tolaney, S.M., Seidman, A.D., Anders, C.K., Ibrahim, N.K., Rugo, H.S., Twelves, C.J., Dieras, V., Müller, V., Hannah, A.L., Tagliaferri, M.A., Cortes Castan, J.

Volltext

Lucitanib for the treatment of HR+ HER2- metastatic breast cancer (MBC) patients (pts): Results from the multicohort phase II FINESSE trial von Hui, R., Pearson, A., Cortes Castan, J., Campbell, C., Poirot, C., Azim, H.A., Fumagalli, D., Lambertini, M., Daly, F., Arahmani, A., Perez-Garcia, J., Aftimos, P.G., Bedard, P., Xuereb, L., Loibl, S., Loi, S., Pierrat, M.-J., Turner, N.C., André, F., Curigliano, G.

Volltext

Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial von Cortes Castan, J., Martín, M., Pernas Simon, S., Gomez Pardo, P., Lopez-Tarruella, S., Gil Martin, M., Manso, L.M., Ciruelos, E.M., Perez Fidalgo, J.A., Hernando, C., Ademuyiwa, F., Weilbaecher, K., Mayer, I.A., Pluard, T., Martinez Garcia, M., Vahdat, L.T., Wach, A., Barker, D., Romagnoli, B., Kaufman, P.A.

Volltext